Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " August 19, 2012":" September 18, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: antiretroviral therapy;   Behavioral: cell phone reminders;   Behavioral: contingency management for adherence
2 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:
3 Completed Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
Condition: HIV Infection
Intervention: Procedure: colonoscopy with endoscopic biopsies
4 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
5 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
6 Suspended Pilot Study of Diflunisal in HIV-infected Adults
Condition: HIV Infection
Intervention: Drug: Diflunisal
7 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
8 Completed Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
9 Unknown  HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
10 Active, not recruiting Screening, Brief Intervention, and Referral to Treatment for Offenders
Conditions: Substance Use;   HIV Infections
Interventions: Behavioral: SBIRT;   Behavioral: Control Group
11 Terminated Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
12 Completed Body Image in Youth With HIV
Conditions: Human Immunodeficiency Virus;   HIV
Intervention: Other: Questionnaire
13 Completed Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
14 Completed Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
Condition: HIV
Interventions: Behavioral: Individual level;   Behavioral: Structural level;   Behavioral: Individual level standard of care;   Behavioral: Structural level standard of care
15 Completed Increasing Availability and Acceptability of Circumcision in Zambia
Condition: HIV
Intervention: Behavioral: MC and sexual risk reduction
16 Completed Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Cardiovascular Diseases;   HIV
Intervention:
17 Completed Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions: Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory Syndrome
Interventions: Other: Urgent ART;   Other: Early ART
18 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
19 Completed Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
20 Completed A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.